Solid Biosciences Inc. — Director's Dealing 2024

Jan 12, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2024-01-11

Reporting Person: RA CAPITAL MANAGEMENT, L.P. (Director, 10% Owner)
Reporting Person: RA Capital Healthcare Fund LP (Director, 10% Owner)
Reporting Person: Kolchinsky Peter (Director, 10% Owner)
Reporting Person: Shah Rajeev M. (Director, 10% Owner)
Reporting Person: RA Capital Nexus Fund, L.P. (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-01-11	Common Stock	P	904160	$5.53	Acquired	4192216	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	109661	Indirect

Footnotes

F1: Acquired from the Issuer pursuant to the Securities Purchase Agreement dated January 8, 2024

F2: Held directly by RA Capital Healthcare Fund, L.P. (the "Fund").

F3: Held directly by RA Capital Nexus Fund, L.P. (the "Nexus Fund").

F4: RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.